{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:49:23Z","timestamp":1790286563500,"version":"4.1.0"},"reference-count":58,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100005645","name":"Scientific Research Project of Ministry of Education and Training","doi-asserted-by":"publisher","award":["B2019-TNA-11"],"award-info":[{"award-number":["B2019-TNA-11"]}],"id":[{"id":"10.13039\/501100005645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Aims:<\/jats:title><jats:p>This study aims are the synthesis of 3-(2-amino-6-arylpyrimidin-4-yl)-4-hydroxy-1- methylquinolin-2(1H)-ones and estimation their anticancer activities on HepG2 and KB cancer lines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background:<\/jats:title><jats:p>Many derivatives of quinoline-2-on have been interested to synthesize and evaluate their biological properties by organic chemists due to their various biological effects, including antibacterial, antioxidant, anti-inflammatory, anticancer activities. Quinoline-pyrimidine hybrid compounds exhibited various biological activities, such as antituberculosis, antibacterial, anticancer, antifungal, etc. The connection of 4-hydroxyquinoline-2-one with 2-amino-pyrimidine could initiate the new activities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>\u03b1,\u03b2-Unsaturated ketones of 3-acetyl-4-hydroxy-N-methylquinolin-2-one were prepared. Novel 2-amino-6-aryl-4-(4\u2032-hydroxy-N-methylquinolin-2\u2032-on-3\u2032-yl)pyrimidines have been synthesized by reaction of these corresponding \u03b1,\u03b2-unsaturated ketones with guanidine hydrochloride. Human hepatocellular carcinoma HepG2 and squamous cell carcinoma KB cancer lines were used for screening their cytotoxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Seven substituted (E)-4-hydroxy-3-(3-(aryl)acryloyl)-1-methylquinolin-2(1H)-ones were prepared and converted to corresponding substituted 2-amino-6-aryl-4-(4\u2032-hydroxy-N-methylquinolin- 2\u2032-on-3\u2032-yl)pyrimidines with yields of 58\u221274%. All the synthesized pyrimidines were screened for their in vitro anticancer activity against human hepatocellular carcinoma HepG2 and squamous cell carcinoma KB cancer lines. Compounds 6b and 6e had the best activity in the series, with IC50 values equal to 1.32 and 1.33 \u03bcM, respectively. ADMET properties showed that compounds 6b, 6e, and 6f possessed the drug-likeness behavior. Cross-docking results indicated that residues GLN778(A), DT8(C), DT9(D), DA12(F), and DG13(F) in the binding pocket as potential ligand binding hot-spot residues for compounds 6b, 6e, and 6f.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>New substituted 2-amino-6-aryl-4-(4\u2032-hydroxy-N-methylquinolin-2\u2032-on-3\u2032-yl)pyrimidines were obtained and displayed significant inhibition against human hepatocellular carcinoma HepG2 and squamous cell carcinoma KB cancer lines.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573406417666201230092615","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T04:00:50Z","timestamp":1609387250000},"page":"36-50","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones"],"prefix":"10.2174","volume":"18","author":[{"given":"Duong Ngoc","family":"Toan","sequence":"first","affiliation":[{"name":"Faculty of Chemistry, Thai Nguyen University of Education, 20 Luong Ngoc Quyen, Thai Nguyen,Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Dinh","family":"Thanh","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, VNU University of Science (Vietnam National University, Ha Noi), 19 Le Thanh Tong, Hoan Kiem, Ha Noi,Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Xuan","family":"Truong","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, Thai Nguyen University of Education, 20 Luong Ngoc Quyen, Thai Nguyen,Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Thuy","family":"Van","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, Thai Nguyen University of Education, 20 Luong Ngoc Quyen, Thai Nguyen,Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s11164-018-3652-1","volume":"45","author":"Abdou M.M.","year":"2019","unstructured":"Abdou M.M.; Sefero&#x11F;lu Z.; Fathy M.; Akitsu T.; Koketsu M.; Kellow R.; Amigues E.; Synthesis and chemical transformations of 3-acetyl-4-hydroxyquinolin-2(1H)-one and N-substituted derivatives: bird\u2019s eye view. Res Chem Intermed 2019,45(3),919-934","journal-title":"Res Chem Intermed"},{"key":"ref=2","first-page":"1949","volume":"21","author":"Karel P.","year":"2017","unstructured":"Karel P.; Stanislav K.; Janez K.; Chemistry and Applications of 4-Hydroxyquinolin-2-one and Quinoline-2,4-dione-based Compounds. Curr Org Chem 2017,21(19),1949-1975","journal-title":"Curr Org Chem"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s41061-019-0234-7","volume":"377","author":"Romero A.H.","year":"2019","unstructured":"Romero A.H.; Role of Trifluoromethyl Substitution in Design of Antimalarial Quinolones: a Comprehensive Review. Top Curr Chem 2019,377(2),9","journal-title":"Top Curr Chem"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jhet.2405","volume":"53","author":"Sharma K.","year":"2016","unstructured":"Sharma K.; Khandelwal S.; Samarth R.M.; Kumar M.; Natural Product-Mimetic Scaffolds with Privileged Heterocyclic Systems: Design, Synthesis, and Evaluation of Antioxidant Activity of Quinazoquinobenzothiazinones. J Heterocycl Chem 2016,53(1),220-228","journal-title":"J Heterocycl Chem"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/np4001366","volume":"76","author":"El-Neketi M.","year":"2013","unstructured":"El-Neketi M.; Ebrahim W.; Lin W.; Gedara S.; Badria F.; Saad H-E.A.; Lai D.; Proksch P.; Alkaloids and Polyketides from Penicillium citrinum, an Endophyte Isolated from the Moroccan Plant Ceratonia siliqua. Journal of Natural Products 2013,76(6),1099-1104","journal-title":"Journal of Natural Products"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02238348","volume":"36","author":"Bessonova I.A.","year":"2000","unstructured":"Bessonova I.A.; Components ofHaplophyllum bucharicum. Chem Nat Compd 2000,36(3),323-324","journal-title":"Chem Nat Compd"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejmech.2014.05.024","volume":"81","author":"Ferretti M.D.","year":"2014","unstructured":"Ferretti M.D.; Neto A.T.; Morel A.F.; Kaufman T.S.; Larghi E.L.; Synthesis of symmetrically substituted 3,3-dibenzyl-4-hydroxy-3,4-dihydro-1H-quinolin-2-ones, as novel quinoline derivatives with antibacterial activity. Eur J Med Chem 2014,81,253-266","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejmech.2017.04.012","volume":"134","author":"Zwergel C.","year":"2017","unstructured":"Zwergel C.; Czepukojc B.; Evain-Bana E.; Xu Z.; Stazi G.; Mori M.; Patsilinakos A.; Mai A.; Botta B.; Ragno R.; Bagrel D.; Kirsch G.; Meiser P.; Jacob C.; Montenarh M.; Valente S.; Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells. Eur J Med Chem 2017,134,316-333","journal-title":"Eur J Med Chem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bmc.2011.11.068","volume":"20","author":"Greeff J.","year":"2012","unstructured":"Greeff J.; Joubert J.; Malan S.F.; van Dyk S.; Antioxidant properties of 4-quinolones and structurally related flavones. Bioorg Med Chem 2012,20(2),809-818","journal-title":"Bioorg Med Chem"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.drudis.2012.11.003","volume":"18","author":"Mukherjee S.","year":"2013","unstructured":"Mukherjee S.; Pal M.; Quinolines: a new hope against inflammation. Drug Discov Today 2013,18(7),389-398","journal-title":"Drug Discov Today"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/jor.20937","volume":"27","author":"Hsu S-C.","year":"2009","unstructured":"Hsu S-C.; Yang J-S.; Kuo C-L.; Lo C.; Lin J-P.; Hsia T-C.; Lin J-J.; Lai K-C.; Kuo H-M.; Huang L-J.; Kuo S-C.; Wood W.G.; Chung J-G.; Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line. J Orthop Res 2009,27(12),1637-1644","journal-title":"J Orthop Res"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0014-827X(01)01123-5","volume":"56","author":"Cocco M.T.","year":"2001","unstructured":"Cocco M.T.; Congiu C.; Onnis V.; Piras R.; Synthesis and antitumor evaluation of 6-thioxo-, 6-oxo- and 2,4-dioxopyrimidine derivatives. Farmaco 2001,56(10),741-748","journal-title":"Farmaco"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.antiviral.2012.01.007","volume":"94","author":"Meneghesso S.","year":"2012","unstructured":"Meneghesso S.; Vanderlinden E.; Stevaert A.; McGuigan C.; Balzarini J.; Naesens L.; Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus. Antiviral Res 2012,94(1),35-43","journal-title":"Antiviral Res"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"S484","DOI":"10.1016\/j.arabjc.2012.10.008","volume":"10","author":"Mallikarjunaswamy C.","year":"2017","unstructured":"Mallikarjunaswamy C.; Mallesha L.; Bhadregowda D.G.; Pinto O.; Studies on synthesis of pyrimidine derivatives and their antimicrobial activity. Arab J Chem 2017,10,S484-S490","journal-title":"Arab J Chem"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.arabjc.2010.12.021","volume":"7","author":"Bhalgat C.M.","year":"2014","unstructured":"Bhalgat C.M.; Irfan Ali M.; Ramesh B.; Ramu G.; Novel pyrimidine and its triazole fused derivatives: Synthesis and investigation of antioxidant and anti-inflammatory activity. Arab J Chem 2014,7(6),986-993","journal-title":"Arab J Chem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40257-014-0077-5","volume":"15","author":"Varothai S.","year":"2014","unstructured":"Varothai S.; Bergfeld W.F.; Androgenetic Alopecia: An Evidence-Based Treatment Update. Am J Clin Dermatol 2014,15(3),217-230","journal-title":"Am J Clin Dermatol"},{"key":"ref=17","first-page":"483","volume":"12","author":"Stellbrink H-J.","year":"2007","unstructured":"Stellbrink H-J.; Antiviral drugs in the treatment of AIDS: what is in the pipeline? Eur J Med Res 2007,12(9),483-495","journal-title":"Eur J Med Res"},{"key":"ref=18","year":"2019","unstructured":"World Health, O World Health Organization model list of essential medicines: 21st list 2019 2019","journal-title":"World Health, O World Health Organization model list of essential medicines: 21st list 2019"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17460441.2016.1187597","volume":"11","author":"Parkes A.L.","year":"2016","unstructured":"Parkes A.L.; Yule I.A.; Hybrid antibiotics \u2013 clinical progress and novel designs. Expert Opin Drug Discov 2016,11(7),665-680","journal-title":"Expert Opin Drug Discov"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1074\/mcp.M112.021014","volume":"12","author":"Yang Y.","year":"2013","unstructured":"Yang Y.; Hahne H.; Kuster B.; Verhelst S.H.L.; A simple and effective cleavable linker for chemical proteomics applications. Mol Cell Proteomics 2013,12(1),237-244","journal-title":"Mol Cell Proteomics"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1039\/C8CS00676H","volume":"48","author":"Bargh J.D.","year":"2019","unstructured":"Bargh J.D.; Isidro-Llobet A.; Parker J.S.; Spring D.R.; Cleavable linkers in antibody\u2013drug conjugates. Chem Soc Rev 2019,48(16),4361-4374","journal-title":"Chem Soc Rev"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2174\/1568026616666160927160620","volume":"17","author":"Pedrosa M.","year":"2017","unstructured":"Pedrosa M.; da Cruz R.; Viana J.; de Moura R.; Ishiki H.; Filho J.M.B.; MFFM Diniz, MT Scotti, L. Scotti, FJBM Junior, Hybrid compounds as direct multitarget ligands: a review. Curr Top Med Chem 2017,17,1044-1079","journal-title":"Curr Top Med Chem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","volume":"11","author":"B&#xE9;rub&#xE9; G.","year":"2016","unstructured":"B&#xE9;rub&#xE9; G.; An overview of molecular hybrids in drug discovery. Expert Opin Drug Discov 2016,11(3),281-305","journal-title":"Expert Opin Drug Discov"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","volume":"141","author":"Hu Y-Q.","year":"2017","unstructured":"Hu Y-Q.; Zhang S.; Xu Z.; Lv Z-S.; Liu M-L.; Feng L-S.; 4-Quinolone hybrids and their antibacterial activities. Eur J Med Chem 2017,141,335-345","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1016\/j.bmc.2015.03.037","volume":"23","author":"Mao T-Q.","year":"2015","unstructured":"Mao T-Q.; He Q-Q.; Wan Z-Y.; Chen W-X.; Chen F-E.; Tang G-F.; De Clercq E.; Daelemans D.; Pannecouque C.; Anti-HIV diarylpyrimidine\u2013quinolone hybrids and their mode of action. Bioorg Med Chem 2015,23(13),3860-3868","journal-title":"Bioorg Med Chem"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2018.11.021","volume":"162","author":"Maurya S.S.","year":"2019","unstructured":"Maurya S.S.; Bahuguna A.; Khan S.I.; Kumar D.; Kholiya R.; Rawat D.S.; N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in vitro antimalarial activity evaluation and docking studies. Eur J Med Chem 2019,162,277-289","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.02.021","volume":"148","author":"Chopra R.","year":"2018","unstructured":"Chopra R.; Chibale K.; Singh K.; Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity. Eur J Med Chem 2018,148,39-53","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2174\/1871520619666190319142934","volume":"19","author":"Heba A.E.M.","year":"2019","unstructured":"Heba A.E.M.; Hossa F.A-S.; Design, Synthesis, Anti-Proliferative Evaluation and Cell Cycle Analysis of Hybrid 2-Quinolones. Anticancer Agents Med Chem 2019,19(9),1132-1140","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103414","volume":"94","author":"Vettorazzi M.","year":"2020","unstructured":"Vettorazzi M.; Insuasty D.; Lima S.; Guti&#xE9;rrez L.; Nogueras M.; Marchal A.; Abonia R.; And&#xFA;jar S.; Spiegel S.; Cobo J.; Enriz R.D.; Design of new quinolin-2-one-pyrimidine hybrids as sphingosine kinases inhibitors. Bioorg Chem 2020,94","journal-title":"Bioorg Chem"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/AAC.01311-05","volume":"51","author":"Butler M.M.","year":"2007","unstructured":"Butler M.M.; Lamarr W.A.; Foster K.A.; Barnes M.H.; Skow D.J.; Lyden P.T.; Kustigian L.M.; Zhi C.; Brown N.C.; Wright G.E.; Bowlin T.L.; Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound. Antimicrob Agents Chemother 2007,51(1),119-127","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=31","year":"2010","unstructured":"Labischinski, H.; Cherian, J.; Calanasan, C.; Boyce, R., Hybrid antimicrobial compounds and their use. WO2010025906 . 2010"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","volume":"70","author":"Champoux J.J.","year":"2001","unstructured":"Champoux J.J.; Topoisomerases D.N.A.; Structure, Function, and Mechanism. Annu Rev Biochem 2001,70(1),369-413","journal-title":"Annu Rev Biochem"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"Aldred K.J.","year":"2014","unstructured":"Aldred K.J.; Kerns R.J.; Osheroff N.; Mechanism of Quinolone Action and Resistance. Biochemistry 2014,53(10),1565-1574","journal-title":"Biochemistry"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2019.03.034","volume":"171","author":"Liang X.","year":"2019","unstructured":"Liang X.; Wu Q.; Luan S.; Yin Z.; He C.; Yin L.; Zou Y.; Yuan Z.; Li L.; Song X.; He M.; Lv C.; Zhang W.; A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade. Eur J Med Chem 2019,171,129-168","journal-title":"Eur J Med Chem"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","volume":"165","author":"Gao F.","year":"2019","unstructured":"Gao F.; Zhang X.; Wang T.; Xiao J.; Quinolone hybrids and their anti-cancer activities: An overview. Eur J Med Chem 2019,165,59-79","journal-title":"Eur J Med Chem"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jlac.1990199001153","volume":"1990","author":"Roschger P.","year":"1990","unstructured":"Roschger P.; Stadlbauer W.; Organic azides in heterocyclic synthesis, 11. Ring closure of 3-acetyl-4-azido-2-quinolones to isoxazolo[4,3-c]quinolones. Liebigs Ann Chem 1990,1990(8),821-823","journal-title":"Liebigs Ann Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jhet.5570210659","volume":"21","author":"Faber K.","year":"1984","unstructured":"Faber K.; Kappe T.; Non-steroidal antiinflammatory agents. 2. Synthesis of 4-hydroxy-1-methyl-2-oxo-dihydroquinolin-3-yl acetic acid and related tetrazolyl derivatives. J Heterocycl Chem 1984,21(6),1881-1883","journal-title":"J Heterocycl Chem"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3987\/COM-91-5823","volume":"32","author":"Ruano J.G.","year":"1991","unstructured":"Ruano J.G.; Pedregal C.; Rodr&#xED;guez J.H.; Synthesis and tautomerism of 2,4-dihydroxyquinolines. Heterocycles 1991,32(11),2151-2159","journal-title":"Heterocycles"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"S3324","DOI":"10.1016\/j.arabjc.2014.01.012","volume":"10","author":"Abdou M.M.","year":"2017","unstructured":"Abdou M.M.; Chemistry of 4-Hydroxy-2(1H)-quinolone. Part 1: Synthesis and reactions. Arab J Chem 2017,10,S3324-S3337","journal-title":"Arab J Chem"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejmech.2012.01.035","volume":"50","author":"Giridhar R.","year":"2012","unstructured":"Giridhar R.; Tamboli R.S.; Ramajayam R.; Prajapati D.G.; Yadav M.R.; Assessment of antiplatelet activity of 2-aminopyrimidines. Eur J Med Chem 2012,50,428-432","journal-title":"Eur J Med Chem"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejmech.2015.09.035","volume":"104","author":"Robinson S.J.","year":"2015","unstructured":"Robinson S.J.; Petzer J.P.; Terre\u2019Blanche, G.; Petzer, A.; van der Walt, M. M.; Bergh, J. J.; Lourens, A. C. U., 2-Aminopyrimidines as dual adenosine A1\/A2A antagonists. Eur J Med Chem 2015,104,177-188","journal-title":"Eur J Med Chem"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2006.09.012","volume":"42","author":"Ingarsal N.","year":"2007","unstructured":"Ingarsal N.; Saravanan G.; Amutha P.; Nagarajan S.; Synthesis, in vitro antibacterial and antifungal evaluations of 2-amino-4-(1-naphthyl)-6-arylpyrimidines. Eur J Med Chem 2007,42(4),517-520","journal-title":"Eur J Med Chem"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.carres.2009.09.002","volume":"344","author":"Thanh N.D.","year":"2009","unstructured":"Thanh N.D.; Mai N.T.T.; Synthesis of N-tetra-O-acetyl-&#x3B2;-D-glucopyranosyl-N\u2032-(4\u2032,6\u2032-diarylpyrimidin-2\u2032-yl)thioureas. Carbohydr Res 2009,344(17),2399-2405","journal-title":"Carbohydr Res"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/9780470915110.ch2","author":"Lagorce D.","year":"2011","unstructured":"Lagorce D.; Reynes C.; Camproux A.C.; Miteva M.A.; Sperandio O.; Villoutreix B.O.; In silico adme\/tox predictions ADMET for Medicinal Chemists 2011,29-124","journal-title":"In silico adme\/tox predictions ADMET for Medicinal Chemists"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"Lipinski C.A.","year":"1997","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997,23(1-3),3-25","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"Veber D.F.","year":"2002","unstructured":"Veber D.F.; Johnson S.R.; Cheng H.Y.; Smith B.R.; Ward K.W.; Kopple K.D.; Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002,45(12),2615-2623","journal-title":"J Med Chem"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"Egan W.J.","year":"2000","unstructured":"Egan W.J.; Merz K.M.; Baldwin J.J.; Prediction of Drug Absorption Using Multivariate Statistics. J Med Chem 2000,43(21),3867-3877","journal-title":"J Med Chem"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1023\/A:1020444330011","volume":"19","author":"Zhao Y.H.","year":"2002","unstructured":"Zhao Y.H.; Abraham M.H.; Le J.; Hersey A.; Luscombe C.N.; Beck G.; Sherborne B.; Cooper I.; Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 2002,19(10),1446-1457","journal-title":"Pharm Res"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1204117","volume":"333","author":"Wu C.C.","year":"2011","unstructured":"Wu C.C.; Li T.K.; Farh L.; Lin L.Y.; Lin T.S.; Yu Y.J.; Yen T.J.; Chiang C.W.; Chan N.L.; Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science 2011,333(6041),459-462","journal-title":"Science"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1021\/ja01517a031","volume":"81","author":"Goodwin S.","year":"1959","unstructured":"Goodwin S.; Smith A.F.; Horning E.C.; Alkaloids of Ochrosia elliptica Labill.1. J Am Chem Soc 1959,81(8),1903-1908","journal-title":"J Am Chem Soc"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(87)90463-2","volume":"259","author":"Auclair C.","year":"1987","unstructured":"Auclair C.; Multimodal action of antitumor agents on DNA: The ellipticine series. Arch Biochem Biophys 1987,259(1),1-14","journal-title":"Arch Biochem Biophys"},{"key":"ref=53","first-page":"98","volume":"4","author":"Stiborov&#xE1; M.","year":"2011","unstructured":"Stiborov&#xE1; M.; Poljakov&#xE1; J.; Mart&#xED;nkov&#xE1; E.; Bo\u0159ek-Dohalsk&#xE1; L.; Eckschlager T.; Kizek R.; Frei E.; Ellipticine cytotoxicity to cancer cell lines - a comparative study. Interdiscip Toxicol 2011,4(2),98-105","journal-title":"Interdiscip Toxicol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2019.01.015","volume":"165","author":"Salerno S.","year":"2019","unstructured":"Salerno S.; La Pietra V.; Hyeraci M.; Taliani S.; Robello M.; Barresi E.; Milite C.; Simorini F.; Garc&#xED;a-Arg&#xE1;ez A.N.; Marinelli L.; Novellino E.; Da Settimo F.; Marini A.M.; Dalla Via L.; Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases. Eur J Med Chem 2019,165,46-58","journal-title":"Eur J Med Chem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1093\/nar\/gkt828","volume":"41","author":"Wu C-C.","year":"2013","unstructured":"Wu C-C.; Li Y-C.; Wang Y-R.; Li T-K.; Chan N-L.; On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs. Nucleic Acids Res 2013,41(22),10630-10640","journal-title":"Nucleic Acids Res"},{"key":"ref=56","first-page":"4827","volume":"48","author":"Scudiero D.A.","year":"1988","unstructured":"Scudiero D.A.; Shoemaker R.H.; Paull K.D.; Monks A.; Tierney S.; Nofziger T.H.; Currens M.J.; Seniff D.; Boyd M.R.; Evaluation of a Soluble Tetrazolium\/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines. Cancer Res 1988,48(17),4827-4833","journal-title":"Cancer Res"},{"key":"ref=57","year":"2018","unstructured":"Schr&#xF6;dinger, suite 2018-4 2018","journal-title":"Schr&#xF6;dinger, suite 2018-4"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"Halgren T.A.","year":"2004","unstructured":"Halgren T.A.; Murphy R.B.; Friesner R.A.; Beard H.S.; Frye L.L.; Pollard W.T.; Banks J.L.; Glide:\u2009A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. J Med Chem 2004,47(7),1750-1759","journal-title":"J Med Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/189614","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/189614\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/189614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T15:32:53Z","timestamp":1697470373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/189614\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406417666201230092615","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}